Jamp K8 Tablet; Out of Specification (Dissolution)
Brand(s)
Last updated
Summary
Product
Jamp K8 Tablet
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot numbers |
|---|---|---|---|---|---|
| Jamp Pharma | Jamp K8 Tablet | NPN 80013005 | Tablet, Extended Release | Potassium Chloride 8.0 mEq (600 mg) | 800226 |
Issue
The dissolution is out of specification in the affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Natural health products
Companies
JAMP Pharma Corporation
1310 Nobel,
Boucherville, Quebec, J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-77073
Get notified
Receive notifications for new and updated recalls and alerts by category.